Remaining performance obligations

Name: Abbott Remaining performance obligations by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Abbott·Business Segments·3 segments·Rolls up to Deferred Revenue

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Diagnostic Products	$4.8B	$5.3B	$5.5B	$5.7B	$5.9B	$6B	$6.1B	$6.2B
Medical Devices	$493M	$466M	$440M	$423M	$427M	$436M	$444M	$429M
Total	—	—	—	—	—	—	—	—

Diagnostic ProductsView metric

Medical DevicesView metric

PharmaceuticalsView metric